Theralase Historical Income Statement

TLT Stock

CAD 0.28 0.01 3.70%

Historical analysis of Theralase Technologies income statement accounts such as Total Other Income Expense Net of 28.2 K, Total Revenue of 1.5 M, Gross Profit of 260.9 K or Cost Of Revenue of 626.3 K can show how well Theralase Technologies performed in making a profits. Evaluating Theralase Technologies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Theralase Technologies's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Theralase Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Theralase Technologies is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theralase Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Theralase Income Statement Analysis

Theralase Technologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Theralase Technologies shareholders. The income statement also shows Theralase investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Theralase Technologies Income Statement Chart

At this time, Theralase Technologies' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to climb to about 36.7 K in 2025, despite the fact that Operating Income is likely to grow to (3.9 M).

Other Operating Expenses Total Operating Expenses Total Revenue Gross Profit

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Theralase Technologies. It is also known as Theralase Technologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Total Revenue

Total revenue comprises all receipts Theralase Technologies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Theralase Technologies minus its cost of goods sold. It is profit before Theralase Technologies operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Theralase Technologies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Theralase Technologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theralase Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Operating Expenses	6.4M	5.7M	6.5M	4.2M
Interest Expense	21.2K	30.4K	35.0K	36.7K

Other Operating Expenses Interest Expense

Theralase Technologies income statement Correlations

	Depreciation And Amortization	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Total Revenue	Gross Profit	Cost Of Revenue	Selling General Administrative	Selling And Marketing Expenses	Research Development	Net Income From Continuing Ops	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.09	0.71	-0.68	-0.77	-0.75	0.7	-0.77	0.56	-0.75	-0.63	0.11	-0.3	0.65	0.47	-0.21	0.81	-0.73	0.25	0.51	0.59
Interest Expense	0.09		-0.42	-0.09	0.34	0.35	-0.42	0.34	0.03	0.35	0.08	-0.35	-0.44	-0.24	-0.49	-0.62	-0.15	0.33	-0.01	0.22	0.54
Other Operating Expenses	0.71	-0.42		-0.38	-0.96	-0.96	1.0	-0.96	0.3	-0.95	-0.64	0.4	0.11	0.83	0.82	0.37	0.83	-0.91	0.14	0.26	0.19
Operating Income	-0.68	-0.09	-0.38		0.48	0.46	-0.37	0.47	-0.22	0.48	0.18	0.23	0.5	-0.37	-0.24	0.31	-0.57	0.49	-0.27	-0.48	-0.39
Ebit	-0.77	0.34	-0.96	0.48		1.0	-0.97	1.0	-0.31	1.0	0.58	-0.21	0.1	-0.73	-0.76	-0.25	-0.9	0.98	-0.22	-0.35	-0.24
Ebitda	-0.75	0.35	-0.96	0.46	1.0		-0.97	1.0	-0.29	1.0	0.57	-0.22	0.09	-0.73	-0.77	-0.27	-0.9	0.98	-0.22	-0.34	-0.23
Total Operating Expenses	0.7	-0.42	1.0	-0.37	-0.97	-0.97		-0.97	0.29	-0.96	-0.62	0.37	0.09	0.8	0.81	0.36	0.85	-0.92	0.14	0.26	0.2
Income Before Tax	-0.77	0.34	-0.96	0.47	1.0	1.0	-0.97		-0.29	1.0	0.57	-0.21	0.1	-0.73	-0.76	-0.26	-0.9	0.98	-0.22	-0.35	-0.24
Total Other Income Expense Net	0.56	0.03	0.3	-0.22	-0.31	-0.29	0.29	-0.29		-0.26	-0.66	0.19	0.0	0.32	0.14	-0.35	0.3	-0.19	0.07	0.17	0.29
Net Income	-0.75	0.35	-0.95	0.48	1.0	1.0	-0.96	1.0	-0.26		0.52	-0.17	0.13	-0.7	-0.77	-0.26	-0.91	0.99	-0.23	-0.35	-0.24
Income Tax Expense	-0.63	0.08	-0.64	0.18	0.58	0.57	-0.62	0.57	-0.66	0.52		-0.64	-0.38	-0.74	-0.34	0.01	-0.45	0.41	-0.08	-0.16	-0.16
Total Revenue	0.11	-0.35	0.4	0.23	-0.21	-0.22	0.37	-0.21	0.19	-0.17	-0.64		0.87	0.61	0.4	0.52	-0.05	-0.08	-0.26	-0.35	-0.26
Gross Profit	-0.3	-0.44	0.11	0.5	0.1	0.09	0.09	0.1	0.0	0.13	-0.38	0.87		0.23	0.09	0.55	-0.32	0.22	-0.36	-0.56	-0.47
Cost Of Revenue	0.65	-0.24	0.83	-0.37	-0.73	-0.73	0.8	-0.73	0.32	-0.7	-0.74	0.61	0.23		0.76	0.32	0.53	-0.64	0.06	0.21	0.09
Selling General Administrative	0.47	-0.49	0.82	-0.24	-0.76	-0.77	0.81	-0.76	0.14	-0.77	-0.34	0.4	0.09	0.76		0.51	0.55	-0.77	0.07	0.15	0.08
Selling And Marketing Expenses	-0.21	-0.62	0.37	0.31	-0.25	-0.27	0.36	-0.26	-0.35	-0.26	0.01	0.52	0.55	0.32	0.51		-0.08	-0.27	-0.19	-0.42	-0.58
Research Development	0.81	-0.15	0.83	-0.57	-0.9	-0.9	0.85	-0.9	0.3	-0.91	-0.45	-0.05	-0.32	0.53	0.55	-0.08		-0.9	0.26	0.49	0.51
Net Income From Continuing Ops	-0.73	0.33	-0.91	0.49	0.98	0.98	-0.92	0.98	-0.19	0.99	0.41	-0.08	0.22	-0.64	-0.77	-0.27	-0.9		-0.23	-0.36	-0.25
Net Interest Income	0.25	-0.01	0.14	-0.27	-0.22	-0.22	0.14	-0.22	0.07	-0.23	-0.08	-0.26	-0.36	0.06	0.07	-0.19	0.26	-0.23		0.88	0.11
Interest Income	0.51	0.22	0.26	-0.48	-0.35	-0.34	0.26	-0.35	0.17	-0.35	-0.16	-0.35	-0.56	0.21	0.15	-0.42	0.49	-0.36	0.88		0.49
Reconciled Depreciation	0.59	0.54	0.19	-0.39	-0.24	-0.23	0.2	-0.24	0.29	-0.24	-0.16	-0.26	-0.47	0.09	0.08	-0.58	0.51	-0.25	0.11	0.49

Click cells to compare fundamentals

Theralase Technologies Account Relationship Matchups

Theralase Technologies income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	272.3K	276.2K	313.2K	286.1K	329.0K	345.5K
Interest Expense	9.7K	5.3K	21.2K	30.4K	35.0K	36.7K
Other Operating Expenses	6.6M	5.3M	6.4M	5.7M	6.5M	4.2M
Operating Income	(5.6M)	(4.5M)	(5.2M)	(4.6M)	(4.1M)	(3.9M)
Ebit	(5.6M)	(4.5M)	(5.2M)	(4.6M)	(4.1M)	(3.9M)
Ebitda	(5.3M)	(4.2M)	(4.9M)	(4.3M)	(3.9M)	(3.7M)
Total Operating Expenses	6.0M	4.9M	5.9M	4.9M	5.6M	3.6M
Income Before Tax	(5.6M)	(4.4M)	(5.2M)	(4.6M)	(4.1M)	(3.9M)
Total Other Income Expense Net	(5.5K)	107.8K	(34.4K)	23.4K	26.9K	28.2K
Net Income	(5.6M)	(4.4M)	(5.2M)	(4.6M)	(4.1M)	(3.9M)
Income Tax Expense	9.7K	5.3K	13.2K	(4.0)	(3.6)	(3.42)
Total Revenue	929.1K	780.6K	1.1M	1.1M	1.2M	1.5M
Gross Profit	269.7K	309.9K	628.2K	305.2K	274.6K	260.9K
Cost Of Revenue	659.4K	470.7K	510.4K	765.2K	879.9K	626.3K
Selling General Administrative	2.0M	1.8M	1.4M	2.0M	2.3M	1.9M
Selling And Marketing Expenses	447.9K	96.8K	88.2K	97.2K	87.5K	83.1K
Research Development	3.4M	2.9M	4.3M	2.8M	3.2M	2.2M
Net Income From Continuing Ops	(5.6M)	(4.4M)	(5.2M)	(4.6M)	(4.1M)	(4.3M)
Net Income Applicable To Common Shares	(7.4M)	(5.6M)	(4.4M)	(5.2M)	(4.7M)	(4.9M)
Net Interest Income	94.0K	17.3K	9.4K	19.4K	22.3K	27.7K
Interest Income	103.7K	22.7K	30.7K	49.8K	57.3K	38.7K
Reconciled Depreciation	272.3K	276.2K	313.2K	286.1K	329.0K	295.4K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Theralase Stock Analysis

When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theralase Historical Income Statement

About Theralase Income Statement Analysis

Theralase Technologies Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Total Revenue

Gross Profit

Theralase Technologies income statement Correlations

Theralase Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theralase Technologies income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Theralase Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Net Income	+ 1.0	Ebitda

Income Before Tax	- 0.97	Total Operating Expenses
Total Operating Expenses	- 0.97	Ebitda
Total Operating Expenses	- 0.97	Ebit
Net Income	- 0.96	Total Operating Expenses
Income Before Tax	- 0.96	Other Operating Expenses
Ebitda	- 0.96	Other Operating Expenses